Correction: Nac1 promotes stemness and regulates myeloid‑derived cell status in triple‑negative breast cancer

Chrispus Ngule¹, Ruyi Shi^{1

2}, Xingcong Ren¹, Hongyan Jia^{1

3}, Felix Oyelami¹, Dong Li¹, Younhee Park¹, Jinhwan Kim⁴, Hami Hemati¹, Yi Zhang^{1

5}, Xiaofang Xiong⁶, Andrew Shinkle¹, Nathan L Vanderford¹, Sara Bachert⁷, Binhua P Zhou⁴, Jianlong Wang⁸, Jianxun Song⁹, Xia Liu¹⁰, Jin-Ming Yang¹¹

Affiliations

¹ Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, 40536, USA.
² Present Address: Department of Cell Biology and Genetics, Shanxi Medical University, Taiyuan, Shanxi, China.
³ Present Address: Department of Breast Surgery, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
⁴ Department of Biochemistry, and Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, 40536, USA.
⁵ Present Address: Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China.
⁶ Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX, 77807, USA.
⁷ Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY, 40536, USA.
⁸ Department of Medicine, Columbia Center for Human Development and Stem Cell Therapies, Columbia University Irving Medical Center, New York, NY, 10032, USA.
⁹ Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX, 77807, USA. jus35@tamu.edu.
¹⁰ Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, 40536, USA. Xia.Liu@uky.edu.
¹¹ Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, 40536, USA. jyang@uky.edu.

PMID: 39358788
PMCID: PMC11448293
DOI: 10.1186/s12943-024-02143-3

Published Erratum

Correction: Nac1 promotes stemness and regulates myeloid‑derived cell status in triple‑negative breast cancer

Chrispus Ngule et al. Mol Cancer. 2024.

. 2024 Oct 3;23(1):220.

doi: 10.1186/s12943-024-02143-3.

Authors

Affiliations

¹ Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, 40536, USA.
² Present Address: Department of Cell Biology and Genetics, Shanxi Medical University, Taiyuan, Shanxi, China.
³ Present Address: Department of Breast Surgery, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
⁴ Department of Biochemistry, and Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, 40536, USA.
⁵ Present Address: Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China.
⁶ Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX, 77807, USA.
⁷ Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY, 40536, USA.
⁸ Department of Medicine, Columbia Center for Human Development and Stem Cell Therapies, Columbia University Irving Medical Center, New York, NY, 10032, USA.
⁹ Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX, 77807, USA. jus35@tamu.edu.
¹⁰ Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, 40536, USA. Xia.Liu@uky.edu.
¹¹ Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, 40536, USA. jyang@uky.edu.

PMID: 39358788
PMCID: PMC11448293
DOI: 10.1186/s12943-024-02143-3

No abstract available

PubMed Disclaimer

Erratum for

NAC1 promotes stemness and regulates myeloid-derived cell status in triple-negative breast cancer.
Ngule C, Shi R, Ren X, Jia H, Oyelami F, Li D, Park Y, Kim J, Hemati H, Zhang Y, Xiong X, Shinkle A, Vanderford NL, Bachert S, Zhou BP, Wang J, Song J, Liu X, Yang JM. Ngule C, et al. Mol Cancer. 2024 Sep 6;23(1):188. doi: 10.1186/s12943-024-02102-y. Mol Cancer. 2024. PMID: 39243032 Free PMC article.

References

1. Ngule C, Shi R, Ren X, et al. NAC1 promotes stemness and regulates myeloid-derived cell status in triple-negative breast cancer. Mol Cancer. 2024;23:188. 10.1186/s12943-024-02102-y. - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- BioMed Central
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction: Nac1 promotes stemness and regulates myeloid‑derived cell status in triple‑negative breast cancer

Affiliations

Correction: Nac1 promotes stemness and regulates myeloid‑derived cell status in triple‑negative breast cancer

Authors

Affiliations

Erratum for

References

Publication types

LinkOut - more resources

Full Text Sources